Home/Filings/4/0000899243-22-000537
4//SEC Filing

NASSHORN PATRICIA 4

Accession 0000899243-22-000537

CIK 0001645460other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:00 PM ET

Size

5.4 KB

Accession

0000899243-22-000537

Insider Transaction Report

Form 4
Period: 2021-12-15
NASSHORN PATRICIA
Chief Business Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-12-15+100,000100,000 total
    Exercise: $11.24Exp: 2031-12-15Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in four equal semi-annual installments beginning on June 15, 2022.

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0001251374

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:00 PM ET
Size
5.4 KB